IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES TAKEDA SUBSIDIARY LISTING
trib utes, pro motes, sells/de tails for other com pa -
nies. Prod uct ranges in clude: phar ma ceu ti cal
prod ucts (branded, unbranded, pre scrip tion,
non-pre scrip tion), hos pi tal pharmaceuticals,
med i cal equip ment, med i cal sup plies, oph thal mic
prod ucts. Es tab lished 1980. 12 pharmaceutical
employees in 2007.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 1-10 (2007)
Con tacts (Pharm): Chair man: George H. Rott
Sub sid iary of: Takeda, Ja pan (12%)
Phar ma ceu ti cal Sales: US$ 3-4 mil lion
Prod ucts (% of Sales by Lead ing 5):
95-100%
Ther a peu tic Classes (% of Sales by Lead ing
5): 95-100%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
ALBUTEIN (pro tein so lu tion)
DIOSPER (var i cose ther apy sys temic)
BECLO-ASMA (corticoid)
BUTO-ASMA (B2-stim u lant)
UROKINASE (fibrinolytic)
Ther a peu tic Range:
blood/plasma sub sti tutes 86%
antiasthma and COPD prod ucts 6%
antivaricosis/antihemorrhoidal prep a ra tions
6%
antithrombotic agents 1%
emol lients/protectives 1%
Lead ing Dose Forms:
in fu sions 86%
pres sur ised aero sols 6%
tab lets 6%
vi als 1%
liq uids 1%
� SWITZERLAND
TAKEDA PHARMA
Full Name: Takeda Pharma AG
Postal Ad dress: Postfach, CH-8853 Lachen
Street Ad dress: Alpenblickstrasse 26, CH-8853
Lachen
Tel: +41 55 451 52 00
Fax: +41 55 451 52 20
Email: info@takeda.ch
Home Page: www.takeda.ch
De scrip tion: Pro moter, sales/detailer. Prod uct
ranges in clude: phar ma ceu ti cal prod ucts
(branded, pre scrip tion). Es tab lished 1998. 43
phar ma ceu ti cal em ploy ees in 2007. Di vi sions in -
clude: Gastroenterology; Car di ol ogy; Diabetes.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 21-50 (2007)
Con tacts (Pharm): Chair man: Jean-Luc De lay;
Com mer cial Op er a tions: Bruno Faerber, Ernst
Meier; Gen eral Con tact: Jean-Luc Delay
Sub sid iary of: Takeda Pharma, Ger many
(100%)
Phar ma ceu ti cal Sales: US$ 45-50 mil lion
Prod ucts (% of Sales by Lead ing 5):
95-100%
Ther a peu tic Classes (% of Sales by Lead ing
5): n.a.
Dose Forms (% of Sales by Lead ing 5): n.a.
Prin ci pal Prod ucts:
AGOPTON (antiulcerant)
ACTOS (antidiabetic oral)
BLOPRESS PLUS (an gio ten sin-II an tag o nist com -
bi na tion)
BLOPRESS (an gio ten sin-II an tag o nist plain)
COMPETACT (antidiabetic oral)
Ther a peu tic Range:
renin-an gio ten sin sys tem agents 42%
drugs used in di a be tes 29%
ant ac ids/antiflatulents/antiulcerants 29%
psychoanaleptics 1%
Lead ing Dose Forms:
tab lets 69%
cap sules 29%
coated tab lets 3%
� TAIWAN
TAKEDA
Full Name: Takeda Chem i cal In dus tries (Tai wan)
Ltd
Street Ad dress: 7th Floor, Great China Build ing,
No 217, Sec 3, Nan king East Road, Tai pei
Tel: +886 2 2712-1112
Fax: +886 2 2712-1118
De scrip tion: Im porter, pro moter, sales/detailer.
Prod uct ranges in clude: phar ma ceu ti cal prod ucts
(branded), hos pi tal pharmaceuticals. Es tab lished
1962. 107 phar ma ceu ti cal em ploy ees in 2006.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 77 (2006)
Con tacts (Pharm): Chair man: Stan ley Lee;
Com mer cial Op er a tions: PoPo Lin, Jackie Tieng;
Man u fac ture: Mr J.D. Wu; Re search & De vel op -
ment: Grace Fang; Gen eral Con tact: Mr C.C. Kuo
Sub sid iary of: Takeda, Ja pan (100%)
© 2009 IMS Health In cor po rated or its af fil i ates Page 128